{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:39:54Z","timestamp":1791488394925,"version":"4.3.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Anoikis resistance, an essential prerequisite for tumor metastasis, is now recognized as a promising target in the fight against tumor progression. However, the detailed mechanisms of anoikis resistance are not fully understood, and drugs targeting anoikis resistance are not currently available. Here we report that NY-ESO-1, a well-known cancer-testis antigen, is linked to a poor prognosis in tumor patients and that it is crucial for anoikis resistance and tumor metastasis. Overexpression of NY-ESO-1 in cancer cells enhanced ERK1\/2 activation, which in turn promoted resistance to anoikis, increased colony formation in soft agar, and facilitated lung metastasis in mice. Conversely, NY-ESO-1 knockdown significantly reduced ERK1\/2 activity, leading to enhanced anoikis, diminished colony formation, and impaired metastatic potential. Mechanistically, NY-ESO-1 acts as a scaffold protein to recruit the deubiquitinase OTUB1 to PP1\u03b1, forming a ternary complex that prevents PP1\u03b1 from being ubiquitinated. The OTUB1\u2019s deubiquitinase activity, not its ability to suppress E2 enzymes, is necessary for reducing polyubiquitination and improving PP1\u03b1 stability. Finally, accumulated PP1\u03b1 proteins significantly activate downstream ERK1\/2. Blockade of ERK1\/2 or knocking down PP1\u03b1 antagonized NY-ESO-1-mediated anoikis resistance. These results not only reveal a previously unrecognized mode for deubiquitinase substrate expansion but also highlight the function of NY-ESO-1 in anoikis resistance and suggest NY-ESO-1 as a novel attractive target for preventing tumor metastasis.<\/jats:p>","DOI":"10.1038\/s41419-025-08017-w","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:20:51Z","timestamp":1759731651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["NY-ESO-1 facilitates anoikis resistance and tumor metastasis by hijacking deubiquitinase OTUB1 to stabilize PP1\u03b1"],"prefix":"10.1038","volume":"16","author":[{"given":"Pengchao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funmilayo O.","family":"Adeshakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liujiang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyun","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixia","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoxuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2258-4564","authenticated-orcid":false,"given":"Dehong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6755-7725","authenticated-orcid":false,"given":"Xiaolu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3745-1860","authenticated-orcid":false,"given":"Xiaochun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8930-5262","authenticated-orcid":false,"given":"Guizhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"8017_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"8017_CR2","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.apsb.2015.07.005","volume":"5","author":"X Guan","year":"2015","unstructured":"Guan X. Cancer metastases: challenges and opportunities. Acta Pharmaceutica Sin B. 2015;5:402\u201318.","journal-title":"Acta Pharmaceutica Sin B"},{"key":"8017_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.canlet.2008.05.029","volume":"272","author":"CD Simpson","year":"2008","unstructured":"Simpson CD, Anyiwe K, Schimmer AD. Anoikis resistance and tumor metastasis. Cancer Lett. 2008;272:177\u201385.","journal-title":"Cancer Lett"},{"key":"8017_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/306879","volume":"2012","author":"YN Kim","year":"2012","unstructured":"Kim YN, Koo KH, Sung JY, Yun UJ, Kim H. Anoikis resistance: an essential prerequisite for tumor metastasis. Int J Cell Biol. 2012;2012:306879.","journal-title":"Int J Cell Biol"},{"key":"8017_CR5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ccell.2017.07.001","volume":"32","author":"B Strilic","year":"2017","unstructured":"Strilic B, Offermanns S. Intravascular Survival and Extravasation of Tumor Cells. Cancer Cell. 2017;32:282\u201393.","journal-title":"Cancer Cell"},{"key":"8017_CR6","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1038\/sj.cdd.4401723","volume":"12","author":"AP Gilmore","year":"2005","unstructured":"Gilmore AP. Anoikis. Cell Death Differ. 2005;12:1473\u20137.","journal-title":"Cell Death Differ"},{"key":"8017_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/path.3000","volume":"226","author":"ML Taddei","year":"2012","unstructured":"Taddei ML, Giannoni E, Fiaschi T, Chiarugi P. Anoikis: an emerging hallmark in health and diseases. J Pathol. 2012;226:380\u201393.","journal-title":"J Pathol"},{"key":"8017_CR8","doi-asserted-by":"crossref","unstructured":"Adeshakin FO, Adeshakin AO, Afolabi LO, Yan D, Zhang G, Wan X. Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming. Front Oncol. 2021;11:626577.","DOI":"10.3389\/fonc.2021.626577"},{"key":"8017_CR9","doi-asserted-by":"publisher","first-page":"e17990","DOI":"10.1097\/MD.0000000000017990","volume":"98","author":"H Wang","year":"2019","unstructured":"Wang H, Chen D, Wang R, Quan W, Xia D, Mei J, et al. NY-ESO-1 expression in solid tumors predicts prognosis: A systematic review and meta-analysis. Medicine (Baltim). 2019;98:e17990.","journal-title":"Medicine (Baltim)"},{"key":"8017_CR10","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3389\/fimmu.2018.00947","volume":"9","author":"R Thomas","year":"2018","unstructured":"Thomas R, Al-Khadairi G, Roelands J, Hendrickx W, Dermime S, Bedognetti D, et al. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives. Front Immunol. 2018;9:947.","journal-title":"Front Immunol"},{"key":"8017_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/annonc\/mdq325","volume":"22","author":"G Curigliano","year":"2011","unstructured":"Curigliano G, Viale G, Ghioni M, Jungbluth AA, Bagnardi V, Spagnoli GC, et al. Cancer-testis antigen expression in triple-negative breast cancer. Ann Oncol. 2011;22:98\u2013103.","journal-title":"Ann Oncol"},{"key":"8017_CR12","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/nm.3910","volume":"21","author":"AP Rapoport","year":"2015","unstructured":"Rapoport AP, Stadtmauer EA, Binder-Scholl GK, Goloubeva O, Vogl DT, Lacey SF, et al. NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma. Nat Med. 2015;21:914\u201321.","journal-title":"Nat Med"},{"key":"8017_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CJI.0000000000000101","volume":"39","author":"TS Park","year":"2016","unstructured":"Park TS, Groh EM, Patel K, Kerkar SP, Lee CC, Rosenberg SA. Expression of MAGE-A and NY-ESO-1 in Primary and Metastatic Cancers. J Immunother. 2016;39:1\u20137.","journal-title":"J Immunother"},{"key":"8017_CR14","first-page":"11","volume":"7","author":"EF Velazquez","year":"2007","unstructured":"Velazquez EF, Jungbluth AA, Yancovitz M, Gnjatic S, Adams S, O\u2019Neill D, et al. Expression of the cancer\/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)-correlation with prognostic factors. Cancer Immun. 2007;7:11.","journal-title":"Cancer Immun"},{"key":"8017_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/his.13498","volume":"73","author":"A Raghavendra","year":"2018","unstructured":"Raghavendra A, Kalita-de Croft P, Vargas AC, Smart CE, Simpson PT, Saunus JM, et al. Expression of MAGE-A and NY-ESO-1 cancer\/testis antigens is enriched in triple-negative invasive breast cancers. Histopathology. 2018;73:68\u201380.","journal-title":"Histopathology"},{"key":"8017_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02272-y","volume":"9","author":"M Chen","year":"2018","unstructured":"Chen M, Wan L, Zhang J, Zhang J, Mendez L, Clohessy JG, et al. Deregulated PP1alpha phosphatase activity towards MAPK activation is antagonized by a tumor suppressive failsafe mechanism. Nat Commun. 2018;9:159.","journal-title":"Nat Commun"},{"key":"8017_CR17","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1016\/j.csbj.2021.07.014","volume":"19","author":"B Gyorffy","year":"2021","unstructured":"Gyorffy B. Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer. Comput Struct Biotechnol J. 2021;19:4101\u20139.","journal-title":"Comput Struct Biotechnol J"},{"key":"8017_CR18","doi-asserted-by":"publisher","first-page":"e82241","DOI":"10.1371\/journal.pone.0082241","volume":"8","author":"B Gyorffy","year":"2013","unstructured":"Gyorffy B, Surowiak P, Budczies J, Lanczky A. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS One. 2013;8:e82241.","journal-title":"PLoS One"},{"key":"8017_CR19","doi-asserted-by":"publisher","first-page":"49322","DOI":"10.18632\/oncotarget.10337","volume":"7","author":"AM Szasz","year":"2016","unstructured":"Szasz AM, Lanczky A, Nagy A, Forster S, Hark K, Green JE, et al. Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients. Oncotarget. 2016;7:49322\u201333.","journal-title":"Oncotarget"},{"key":"8017_CR20","doi-asserted-by":"publisher","first-page":"e27633","DOI":"10.2196\/27633","volume":"23","author":"A Lanczky","year":"2021","unstructured":"Lanczky A, Gyorffy B. Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation. J Med Internet Res. 2021;23:e27633.","journal-title":"J Med Internet Res"},{"key":"8017_CR21","doi-asserted-by":"crossref","unstructured":"Gyorffy B. Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer. Geroscience. 2023.","DOI":"10.1007\/s11357-023-00742-4"},{"key":"8017_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-96340-5","volume":"11","author":"A Osz","year":"2021","unstructured":"Osz A, Lanczky A, Gyorffy B. Survival analysis in breast cancer using proteomic data from four independent datasets. Sci Rep. 2021;11:16787.","journal-title":"Sci Rep"},{"key":"8017_CR23","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1158\/0008-5472.CAN-18-2603","volume":"79","author":"G Zhang","year":"2019","unstructured":"Zhang G, Li X, Chen Q, Li J, Ruan Q, Chen YH, et al. CD317 Activates EGFR by Regulating Its Association with Lipid Rafts. Cancer Res. 2019;79:2220\u201331.","journal-title":"Cancer Res"},{"key":"8017_CR24","doi-asserted-by":"crossref","unstructured":"Chen T, Chen X, Zhang S, Zhu J, Tang B, Wang A, et al. The Genome Sequence Archive Family: Toward Explosive Data Growth and Diverse Data Types. Genomics, proteomics & bioinformatics. 2021;19:578\u2013583.","DOI":"10.1016\/j.gpb.2021.08.001"},{"key":"8017_CR25","doi-asserted-by":"publisher","first-page":"D18","DOI":"10.1093\/nar\/gkad1078","volume":"52","author":"Database Resources of the National Genomics Data Center.","year":"2024","unstructured":"Database Resources of the National Genomics Data Center. China National Center for Bioinformation in 2024. Nucleic Acids Res. 2024;52:D18\u2013D32.","journal-title":"Nucleic Acids Res"},{"key":"8017_CR26","doi-asserted-by":"crossref","unstructured":"Rodriguez-Bautista R, Caro-Sanchez CH, Cabrera-Galeana P, Alanis-Funes GJ, Gutierrez-Millan E, Avila-Rios S, et al. Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior. Cancers (Basel). 2021;13:6256.","DOI":"10.3390\/cancers13246256"},{"key":"8017_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/celldisc.2016.19","volume":"2","author":"S Yoshino","year":"2016","unstructured":"Yoshino S, Hara T, Nakaoka HJ, Kanamori A, Murakami Y, Seiki M, et al. The ERK signaling target RNF126 regulates anoikis resistance in cancer cells by changing the mitochondrial metabolic flux. Cell Discov. 2016;2:16019.","journal-title":"Cell Discov"},{"key":"8017_CR28","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1016\/j.bbamcr.2013.06.026","volume":"1833","author":"P Paoli","year":"2013","unstructured":"Paoli P, Giannoni E, Chiarugi P. Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta. 2013;1833:3481\u201398.","journal-title":"Biochim Biophys Acta"},{"key":"8017_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.68","volume":"8","author":"WD Mahauad-Fernandez","year":"2017","unstructured":"Mahauad-Fernandez WD, Okeoma CM. Cysteine-linked dimerization of BST-2 confers anoikis resistance to breast cancer cells by negating proapoptotic activities to promote tumor cell survival and growth. Cell Death Dis. 2017;8:e2687.","journal-title":"Cell Death Dis"},{"key":"8017_CR30","doi-asserted-by":"publisher","first-page":"M111.013284","DOI":"10.1074\/mcp.M111.013284","volume":"10","author":"SA Wagner","year":"2011","unstructured":"Wagner SA, Beli P, Weinert BT, Nielsen ML, Cox J, Mann M, et al. A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Molecular Cell Proteom : Mcp. 2011;10:M111.013284.","journal-title":"Molecular Cell Proteom : Mcp"},{"key":"8017_CR31","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1074\/mcp.O112.027094","volume":"12","author":"ND Udeshi","year":"2013","unstructured":"Udeshi ND, Svinkina T, Mertins P, Kuhn E, Mani DR, Qiao JW, et al. Refined preparation and use of anti-diglycine remnant (K-\u03b5-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments. Molecular Cell Proteom : Mcp. 2013;12:825\u201331.","journal-title":"Molecular Cell Proteom : Mcp"},{"key":"8017_CR32","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1038\/sj.onc.1204526","volume":"20","author":"M Jaumot","year":"2001","unstructured":"Jaumot M, Hancock JF. Protein phosphatases 1 and 2A promote Raf-1 activation by regulating 14-3-3 interactions. Oncogene. 2001;20:3949\u201358.","journal-title":"Oncogene"},{"key":"8017_CR33","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.cell.2005.11.007","volume":"123","author":"SM Nijman","year":"2005","unstructured":"Nijman SM, Luna-Vargas MP, Velds A, Brummelkamp TR, Dirac AM, Sixma TK, et al. A genomic and functional inventory of deubiquitinating enzymes. Cell. 2005;123:773\u201386.","journal-title":"Cell"},{"key":"8017_CR34","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ebiom.2019.08.061","volume":"48","author":"H Sun","year":"2019","unstructured":"Sun H, Ou B, Zhao S, Liu X, Song L, Liu X, et al. USP11 promotes growth and metastasis of colorectal cancer via PPP1CA-mediated activation of ERK\/MAPK signaling pathway. EBioMedicine. 2019;48:236\u201347.","journal-title":"EBioMedicine"},{"key":"8017_CR35","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/j.celrep.2020.01.015","volume":"30","author":"AS Jahan","year":"2020","unstructured":"Jahan AS, Biquand E, Mu\u00f1oz-Moreno R, Le Quang A, Mok CK, Wong HH, et al. OTUB1 Is a Key Regulator of RIG-I-Dependent Immune Signaling and Is Targeted for Proteasomal Degradation by Influenza A NS1. Cell Rep. 2020;30:1570\u201384.e6.","journal-title":"Cell Rep"},{"key":"8017_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70020","volume":"14","author":"A Alsalloum","year":"2024","unstructured":"Alsalloum A, Shevchenko JA, Sennikov S. NY-ESO-1 antigen: A promising frontier in cancer immunotherapy. Clinical Transl Med. 2024;14:e70020.","journal-title":"Clinical Transl Med"},{"key":"8017_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1615\/CritRevOncog.v18.i1-2.40","volume":"18","author":"TN Seyfried","year":"2013","unstructured":"Seyfried TN, Huysentruyt LC. On the origin of cancer metastasis. Crit Rev Oncog. 2013;18:43\u201373.","journal-title":"Crit Rev Oncog"},{"key":"8017_CR38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.semcancer.2019.08.019","volume":"60","author":"C D\u2019Alterio","year":"2020","unstructured":"D\u2019Alterio C, Scala S, Sozzi G, Roz L, Bertolini G. Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion. Semin Cancer Biol. 2020;60:351\u201361.","journal-title":"Semin Cancer Biol"},{"key":"8017_CR39","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1007\/s00018-016-2210-5","volume":"73","author":"M Vilalta","year":"2016","unstructured":"Vilalta M, Rafat M, Graves EE. Effects of radiation on metastasis and tumor cell migration. Cell Mol Life Sci. 2016;73:2999\u20133007.","journal-title":"Cell Mol Life Sci"},{"key":"8017_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s10020-018-0015-8","volume":"24","author":"N Sundahl","year":"2018","unstructured":"Sundahl N, Duprez F, Ost P, De Neve W, Mareel M. Effects of radiation on the metastatic process. Mol Med. 2018;24:16.","journal-title":"Mol Med"},{"key":"8017_CR41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/00002371-200103000-00010","volume":"24","author":"TS Weiser","year":"2001","unstructured":"Weiser TS, Guo ZS, Ohnmacht GA, Parkhurst ML, Tong-On P, Marincola FM, et al. Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1. Journal Immunother (Hagerstown, Md: 1997). 2001;24:151\u201361.","journal-title":"Journal Immunother (Hagerstown, Md: 1997)"},{"key":"8017_CR42","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/jcp.29128","volume":"235","author":"F Li","year":"2020","unstructured":"Li F, Zhao F, Li M, Pan M, Shi F, Xu H, et al. Decreasing New York esophageal squamous cell carcinoma 1 expression inhibits multiple myeloma growth and osteolytic lesions. Journal Cell Physiol. 2020;235:2183\u201394.","journal-title":"Journal Cell Physiol"},{"key":"8017_CR43","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/carcin\/bgm246","volume":"29","author":"ME Castro","year":"2008","unstructured":"Castro ME, Ferrer I, Cascon A, Guijarro MV, Lleonart M, Cajal SRY, et al. PPP1CA contributes to the senescence program induced by oncogenic Ras. Carcinogenesis. 2008;29:491\u20139.","journal-title":"Carcinogenesis"},{"key":"8017_CR44","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.immuni.2012.11.018","volume":"38","author":"E Wies","year":"2013","unstructured":"Wies E, Wang MK, Maharaj NP, Chen K, Zhou S, Finberg RW, et al. Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling. Immunity. 2013;38:437\u201349.","journal-title":"Immunity"},{"key":"8017_CR45","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/j.1742-4658.2012.08509.x","volume":"280","author":"W Peti","year":"2013","unstructured":"Peti W, Nairn AC, Page R. Structural basis for protein phosphatase 1 regulation and specificity. FEBS J. 2013;280:596\u2013611.","journal-title":"FEBS J"},{"key":"8017_CR46","doi-asserted-by":"publisher","first-page":"5517","DOI":"10.1038\/sj.onc.1209563","volume":"25","author":"LC Hsu","year":"2006","unstructured":"Hsu LC, Huang X, Seasholtz S, Potter DM, Gollin SM. Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines. Oncogene. 2006;25:5517\u201326.","journal-title":"Oncogene"},{"key":"8017_CR47","doi-asserted-by":"crossref","unstructured":"Chen JM, Chen KC, Chiu SC, Chen RY, Hsia JY, Huang YJ, et al. Differential contribution of protein phosphatase 1alpha to cell transformation of different cell types. Oncol Rep. 2019.","DOI":"10.3892\/or.2019.7272"},{"key":"8017_CR48","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0960-9822(06)00185-0","volume":"7","author":"N Berndt","year":"1997","unstructured":"Berndt N, Dohadwala M, Liu CW. Constitutively active protein phosphatase 1alpha causes Rb-dependent G1 arrest in human cancer cells. Curr Biol. 1997;7:375\u201386.","journal-title":"Curr Biol"},{"key":"8017_CR49","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/mc.20191","volume":"45","author":"CW Liu","year":"2006","unstructured":"Liu CW, Wang RH, Berndt N. Protein phosphatase 1alpha activity prevents oncogenic transformation. Mol Carcinog. 2006;45:648\u201356.","journal-title":"Mol Carcinog"},{"key":"8017_CR50","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.1038\/sj.onc.1204829","volume":"20","author":"RH Wang","year":"2001","unstructured":"Wang RH, Liu CW, Avramis VI, Berndt N. Protein phosphatase 1alpha-mediated stimulation of apoptosis is associated with dephosphorylation of the retinoblastoma protein. Oncogene. 2001;20:6111\u201322.","journal-title":"Oncogene"},{"key":"8017_CR51","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.4049\/jimmunol.177.4.2441","volume":"177","author":"F Dessauge","year":"2006","unstructured":"Dessauge F, Cayla X, Albar JP, Fleischer A, Ghadiri A, Duhamel M, et al. Identification of PP1alpha as a caspase-9 regulator in IL-2 deprivation-induced apoptosis. J Immunol. 2006;177:2441\u201351.","journal-title":"J Immunol"},{"key":"8017_CR52","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1093\/emboj\/19.10.2237","volume":"19","author":"V Ayllon","year":"2000","unstructured":"Ayllon V, Martinez AC, Garcia A, Cayla X, Rebollo A. Protein phosphatase 1alpha is a Ras-activated Bad phosphatase that regulates interleukin-2 deprivation-induced apoptosis. EMBO J. 2000;19:2237\u201346.","journal-title":"EMBO J"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08017-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08017-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08017-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:07:36Z","timestamp":1759777656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08017-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8017"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08017-w","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"25 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study did not involve human participants and therefore required no ethical approval or informed consent. All animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of the Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences (Approval No. SIAT-IACUC-190724-YYS-DT-A0811), and were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"682"}}